Africa In Vitro Diagnostics Market by Product & Solution, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User ? Forecast to 2030
The Africa IVD market is expected to grow at a CAGR of 2.8% from 2023 to 2030 to reach $1.49 billion by 2030.

After a comprehensive secondary and primary research study and an in-depth analysis of the market scenario, the report provides the key drivers, restraints, challenges, and opportunities in the Africa IVD market.

The high prevalence of infectious diseases, the rising burden of chronic diseases, the rising initiatives to support the healthcare sector, and the growing awareness about the importance of early disease diagnosis are the major drivers for the Africa IVD market. However, poor healthcare facilities and infrastructure in African countries are the major challenges to the market’s growth.

Based on product category, in 2023, the reagents & kits segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the frequent use of assays & kits in the detection of various chronic diseases coupled with the high burden of infectious diseases in African countries.

Based on technology, in 2023, the molecular diagnostics segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to its advantages such as high sensitivity and accuracy, high throughput capability, and the rising prevalence of infectious diseases.

Based on application, in 2023, the infectious diseases segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is primarily attributed to the high prevalence of infectious diseases such as COVID-19, dengue, HIV, and Chagas disease in the region and the rising initiatives to boost testing capabilities.

Based on diagnostic approach, in 2023, the lab testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the availability of several IVD tests and the higher accuracy offered by laboratory testing.

Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the high demand for IVD diagnostics and the higher preference for hospitals as the primary center of care.

Based on geography, in 2023, South Africa is expected to account for the largest share of this market. The major share of this region is mainly attributed to the high burden of diseases, the rising geriatric population, the increasing initiatives to promote diagnostic testing, and continuous efforts to develop healthcare infrastructure and promote awareness.

The key companies operating in the Africa IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioM?rieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).

Scope of the Report
Africa IVD Market Assessment–by Product Category

  • Reagents & Kits
  • Instruments
  • Software & Services


Africa IVD Market Assessment–by Technology

  • Molecular Diagnostics
  • Point-of-care Diagnostics
  • Immunoassay/Immunochemistry
  • Biochemistry/Clinical Chemistry
  • Whole Blood Glucose Monitoring
  • Hematology
  • Microbiology
  • Coagulation & Hemostasis
  • Other IVD Technologies


Note: Other technologies include urinalysis, hybridization, and loop-mediated amplification.


Africa IVD Market Assessment–by Application

  • Infectious Diseases
  • Oncology
  • Diabetes
  • Cardiology
  • Nephrology
  • Autoimmune Disorders
  • Other Applications


Note: Other applications include toxicology, gastroenterology, neonatal, genetic, and neurological disorders.


Africa IVD Market Assessment–by Diagnostic Approach

  • Lab Testing
  • Point-of-care Testing
  • OTC/Self-testing



Africa IVD Market Assessment–by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care
  • Other End Users


Note: Other end users include long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories.


Africa IVD Market Assessment–by Country

  • South Africa
  • Egypt
  • Algeria
  • Nigeria
  • Morocco
  • Kenya
  • Tunisia
  • Tanzania
  • Rest of Africa